Adaptimmune Therapeutics
ADAP
#9421
Rank
A$96.31 M
Marketcap
$0.37
Share price
-12.60%
Change (1 day)
-81.91%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)